Jafco Super V3 Investment Limited Partnership Insider Profile
4 Followers
Jafco Super V3 Investment Limited Partnership, Ten Percent Owner at TRACON Pharmaceuticals, holds 1.50M shares in TRACON Pharmaceuticals (Ticker: TCON), holds 1.92M shares in Carisma Therapeutics (Ticker: CARM). Most recently, Jafco Super V3 Investment Limited Partnership Sold ― shares of TRACON Pharmaceuticals on Oct 19, 2015 for an estimated value of 14.84K.
Jafco Super V3 Investment Limited Partnership insider profile FAQ
What is the percentage of profitable transactions made by Jafco Super V3 Investment Limited Partnership?
The percentage of profitable transactions made by Jafco Super V3 Investment Limited Partnership is 100%.
What is the average return per transaction made by Jafco Super V3 Investment Limited Partnership?
The average return per transaction made by Jafco Super V3 Investment Limited Partnership is 56.50%.
What stocks does Jafco Super V3 Investment Limited Partnership hold?
Jafco Super V3 Investment Limited Partnership holds: TCON, CARM stocks.
What was Jafco Super V3 Investment Limited Partnership’s latest transaction?
Jafco Super V3 Investment Limited Partnership latest transaction was an Informative Sell of $14.84K.
What was Jafco Super V3 Investment Limited Partnership's most profitable transaction?
Jafco Super V3 Investment Limited Partnership’s most profitable transaction was an Informative Sell of CARM stock on February 3, 2015. The return on the trade was 97.40%.
What is Jafco Super V3 Investment Limited Partnership's role in TRACON Pharmaceuticals?
Jafco Super V3 Investment Limited Partnership's role in TRACON Pharmaceuticals is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.